Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 4
2009 4
2010 4
2011 6
2012 5
2013 5
2014 6
2015 1
2016 4
2017 5
2018 2
2019 1
2021 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
DOCK2: A novel FLT3/ITD leukemia drug target.
Wu M, Small D, Duffield AS. Wu M, et al. Oncotarget. 2017 Sep 30;8(51):88253-88254. doi: 10.18632/oncotarget.21390. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179430 Free PMC article. No abstract available.
Mechanisms of resistance to FLT3 inhibitors.
Chu SH, Small D. Chu SH, et al. Drug Resist Updat. 2009 Feb-Apr;12(1-2):8-16. doi: 10.1016/j.drup.2008.12.001. Epub 2009 Jan 21. Drug Resist Updat. 2009. PMID: 19162530 Free PMC article. Review.
Targeting FLT3 for the treatment of leukemia.
Small D. Small D. Semin Hematol. 2008 Jul;45(3 Suppl 2):S17-21. doi: 10.1053/j.seminhematol.2008.07.007. Semin Hematol. 2008. PMID: 18760705 Free PMC article. Review.
FLT3 inhibitors for the treatment of autoimmune disease.
Whartenby KA, Small D, Calabresi PA. Whartenby KA, et al. Expert Opin Investig Drugs. 2008 Nov;17(11):1685-92. doi: 10.1517/13543784.17.11.1685. Expert Opin Investig Drugs. 2008. PMID: 18922105 Free PMC article. Review.
Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.
Lee LY, Hernandez D, Rajkhowa T, Smith SC, Raman JR, Nguyen B, Small D, Levis M. Lee LY, et al. Blood. 2017 Jan 12;129(2):257-260. doi: 10.1182/blood-2016-10-745133. Epub 2016 Dec 1. Blood. 2017. PMID: 27908881 Free PMC article. No abstract available.
Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.
Kats LM, Reschke M, Taulli R, Pozdnyakova O, Burgess K, Bhargava P, Straley K, Karnik R, Meissner A, Small D, Su SM, Yen K, Zhang J, Pandolfi PP. Kats LM, et al. Cell Stem Cell. 2014 Mar 6;14(3):329-41. doi: 10.1016/j.stem.2013.12.016. Epub 2014 Jan 16. Cell Stem Cell. 2014. PMID: 24440599 Free PMC article.
45 results